Donald Trump Embraces Another Despot I don't recall

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
253
Quote:
Donald Trump Embraces Another Despot

I don't recall seeing Castro in the WH. But this murderous, authoritarian prick has an invite.

Funny, Trump's weakness for authoritarian, insulting pricks like himself, eh?


By THE EDITORIAL BOARDMAY 1, 2017

The United States has long seen itself as a beacon of democracy and a global advocate of human rights and the rule of law. It has faltered, sometimes badly, undermining leaders whose views did not fit its strategic objectives and replacing them with pliant despots. Yet for the most part American presidents, Republican and Democratic, have believed that the United States should provide a moral compass to the world, encouraging people to pursue their right to self-government and human dignity and rebuking foreign leaders who fall short.

Like so much else under President Trump, though, this idea has now been turned on its head and people are worried about the very survival of the values on which America built its reputation and helped construct an entire international system, including the United Nations. The latest example is Mr. Trump’s decision to invite Rodrigo Duterte, the president of the Philippines, to the White House.

Though the Philippines is an ally and a democracy, Mr. Duterte is neither a democratic leader nor a worthy ally. For about two decades as mayor of Davao, he was accused of allowing death squads to roam the city and kill freely. Most victims were poor drug users and low-level criminals, but bystanders, children and political opponents were also caught up in the bloodshed.


After his election last year, Mr. Duterte took the killing campaign nationwide, effectively giving free license to the police and vigilantes. He has boasted about his tenure in Davao, and admitted to personally killing three kidnappers without trial.

The mayhem got so bad that last week a Filipino lawyer formally asked the International Criminal Court to charge Mr. Duterte and 11 officials with mass murder and crimes against humanity over the extrajudicial killings of nearly 10,000 people over the past three decades.


During the last administration, Mr. Duterte disrespected President Barack Obama by calling him the “son of a whore” and threatened to abandon his country’s alliance with the United States for one with China. This is obviously not a man who should be welcomed to the White House.

Mr. Trump extended his invitation in a telephone call that was described as “very friendly.” Administration officials said the call was one of several the president made to reassure Southeast Asian leaders of America’s continuing commitment at a time when they were feeling neglected over Mr. Trump’s focus on China, Japan and North Korea. Administration officials said that Mr. Trump was looking to mend ties with the Philippines as a hedge against China’s expansion in the South China Sea.

But there is no evidence that he consulted the State Department, or that the White House has done anything to prepare the groundwork for a Duterte visit. The normal way to mend diplomatic ties is to negotiate privately over months and have the process culminate in, not begin with, a White House meeting.

What is not in any doubt is Mr. Trump’s own authoritarian tendencies and his fondness for other strongman leaders who, like him, chafe at governmental checks and balances, including the courts. Mr. Trump reportedly admires Mr. Duterte’s aggressive rhetoric about fighting the Islamic State and cracking down on drugs.

He has praised President Recep Tayyip Erdogan of Turkey for winning a disputed referendum that will give him vastly more power and invited him to the White House on May 16. He has already given a friendly reception to President Abdel Fattah el-Sisi of Egypt, who was barred from the White House after staging a coup four years ago and arresting thousands of political opponents.

He has replaced harsh criticism of China with praise for President Xi Jinping, and in the past displayed a bizarre affection for Russia’s Vladimir Putin.

American presidents must work with foreign leaders of all kinds to advance the national interest. But Mr. Trump erodes America’s reputation when he uncritically embraces those who show the least regard for human rights, rule of law and democracy.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 22

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 20

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 23

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 13

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 20

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 17

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 18

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 17

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading

Top 5 Most Recently Viewed Articles

Taitron's Strategic Shift: Nasdaq Delisting and Financial Update

Updated Category News Views 251

Overview of Taitron's Recent Developments Taitron Components Incorporated (NASDAQ: TAIT) recently made headlines by announcing its voluntary delisting from The Nasdaq Stock Market. The company's decision came as it recognized that the cost of maintaining its Nasdaq listing outweighed the benefits for its shareholders. Reasons Behind the Delisting The board concluded that...

Continue Reading
Merck's Two-Drug HIV Treatment Achieves Trial Success

Updated Category News Views 130

Merck's Groundbreaking Two-Drug Regimen for HIV Treatment Recently, Merck & Co Inc (NYSE: MRK) announced promising results from two important Phase 3 clinical trials. This involved their investigational two-drug regimen combining doravirine and islatravir (DOR/ISL) aimed at treating adults living with HIV-1 infection. Key Findings from the Trials The trials were designed...

Continue Reading
Immunic’s Patent Milestone for Vidofludimus Calcium in MS

Updated Category News Views 230

Immunic Achieves Patent Allowance for Vidofludimus Calcium Immunic, Inc. (Nasdaq: IMUX), a leading biotechnology firm, has recently marked a significant milestone by receiving a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application focused on the use of vidofludimus calcium, particularly in the treatment of progressive...

Continue Reading
Creatd, Inc. Advances with OTCQB Approval and Strong Equity

Updated Category News Views 148

Creatd, Inc. Takes a Significant Step with OTCQB Approval Creatd, Inc. (OTC: CRTD) has reached a significant milestone by being approved to trade on the OTCQB Venture Market. This remarkable achievement showcases the company's dedication and progress towards enhancing its market presence. Starting from a pivotal date, Creatd will now be traded on a more recognized...

Continue Reading
KROMATID Unveils Groundbreaking KROMASURE PinPoint Technology

Updated Category News Views 155

KROMATID Launches KROMASURE PinPoint for Enhanced Genomic Analysis With an aim to transform gene therapy development, KROMATID has unveiled its innovative KROMASURE PinPoint system. This next-generation platform revolutionizes transgene integration analysis by providing single-cell resolution that was previously unattainable. Researchers now have the ability to detect...

Continue Reading